You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

A method to assess safety and resilience in radiopharmaceuticals production process

Issue title: IEA 2012: 18th World congress on Ergonomics - Designing a sustainable future

Article type: Research Article

Authors: Grecco, Cláudio H. S. | Vidal, Mario C.R. | Santos, Isaac J. A. L. | Carvalho, Paulo V. R.

Affiliations: Instituto de Engenharia Nuclear (IEN – CNEN/RJ),Divisão de Instrumentação e Confiabilidade Humana Rua Hélio de Almeida, 75, Cidade Universitária - Ilha do Fundão, 21941-906 Rio de Janeiro | Programa de Engenharia de Produção (PEP – COPPE/UFRJ), Grupo de Ergonomia e Novas Tecnologias (GENTE), Av.Horácio Macedo, 2030 - Bloco G - Sala G 207 - Prédio do Centro de Tecnologia, Cidade Universitária - Ilha do Fundão, 21941-914 Rio de Janeiro, RJ, mvidal@ergonomia.ufrj.br

Note: [] grecco@ien.gov.br

Note: [] luquetti@ien.gov.br

Note: [] paulov@ien.gov.br

Keywords: ergonomics, resilience, indicators, performance, accidents

DOI: 10.3233/WOR-2012-0969-5839

Journal: Work, vol. 41, no. Supplement 1, pp. 5839-5843, 2012

Published: 2012
Get PDF

Abstract

Radiopharmaceuticals are radiation-emitting substances used in medicine for radiotherapy and imaging diagnosis. A Research Institute, located in Rio de Janeiro, produces three radiopharmaceuticals: the sodium iodate is used in the diagnosis of thyroid dysfunctions, the meta-iodo-benzylguanidine is used in the diagnosis of cardiac diseases, and the fluordesoxyglucose is used in diagnosis in cardiology, oncology, neurology and neuropsychiatry. This paper presents a method to access safety and resilience in radiopharmaceuticals production processes. The method uses resilience indicators in order to proactively evaluate and manage the safety.

Show more